CART-38 in Adult AML and MM Patients
Summary
Third Opinion Trial Synopsis:
Scientists are doing a study to see if it is safe and possible to make T cells with a special kind of protein on them to help fight cancer. They will use these T cells to help people with two kinds of cancer called Acute Myeloid Leukemia and Multiple Myeloma. The special T cells are called CART-38 cells.
Scientists are doing a study to see if it is safe and possible to make T cells with a special kind of protein on them to help fight cancer. They will use these T cells to help people with two kinds of cancer called Acute Myeloid Leukemia and Multiple Myeloma. The special T cells are called CART-38 cells.
*Third Opinion AI Generated Synopsis
Trial Summary
This is an open-label Phase 1 study to estimate the safety and manufacturing feasibility of lentivirally transduced T cells expressing anti-CD38 chimeric antigen receptors expressing tandem TCRζ and 4-1BB (TCRζ /4-1BB) costimulatory domains in patients with Acute Myeloid Leukemia and Multiple Myeloma. This CAR T cell product will be referred to as "CART-38 cells".
This is an open-label Phase 1 study to estimate the safety and manufacturing feasibility of lentivirally transduced T cells expressing anti-CD38 chimeric antigen receptors expressing tandem TCRζ and 4-1BB (TCRζ /4-1BB) costimulatory domains in patients with Acute Myeloid Leukemia and Multiple Myeloma. This CAR T cell product will be referred to as "CART-38 cells".
Locations & Contact
Fill out the form and "Notify Multiple Myeloma Research Foundation" to let the Multiple Myeloma Research Foundation know you are interested in this trial.
Contacts: